Central Precocious Puberty Caused by a Heterozygous Deletion in the MKRN3 Promoter Region
Carregando...
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Autores
ABREU, Ana Paula
KAISER, Ursula B.
Citação
NEUROENDOCRINOLOGY, v.107, n.2, p.127-132, 2018
Resumo
Context: Loss-of-function mutations in the coding region of MKRN3, a maternally imprinted gene at chromosome 15q11.2, are a common cause of familial central precocious puberty (CPP). Whether MKRN3 alterations in regulatory regions can cause CPP has not been explored to date. We aimed to investigate potential pathogenic variants in the promoter region of MKRN3 in patients with idiopathic CPP. Patients/Methods: A cohort of 110 patients with idiopathic CPP was studied. Family history of precocious sexual development was present in 25%. Mutations in the coding region of MKRN3 were excluded in all patients. Genomic DNA was extracted from peripheral blood leukocytes, and 1,100 nucleotides (nt) of the 5'-regulatory region of MKRN3 were amplified and sequenced. Luciferase assays were performed in GT1-7 cells transiently transfected with plasmids containing mutated and wild-type MKRN3 promoter. Results: We identified a rare heterozygous 4-nt deletion (c.-150_-147delTCAG; -38 to -41 nt upstream to the transcription start site) in the proximal promoter region of MKRN3 in a girl with CPP. In silico analysis predicted that this deletion would lead to the loss of a binding site for a downstream responsive element antagonist modulator (DREAM), a potential transcription factor for MKRN3 and GNRH1 expression. Luciferase assays demonstrated a significant reduction of MKRN3 promoter activity in transfected cells with a c.-150_-147delTCAG construct plasmid in both homozygous and heterozygous states when compared with cells transfected with the corresponding wild-type MKRN3 promoter region. Conclusion: A rare genetic alteration in the regulatory region of MKRN3 causes CPP. (c) 2018 S. Karger AG, Basel
Palavras-chave
Central precocious puberty, MKRN3 promoter region, Genetic alteration, Regulatory region
Referências
- Abreu AP, 2016, LANCET DIABETES ENDO, V4, P254, DOI 10.1016/S2213-8587(15)00418-0
- Abreu AP, 2015, J MOL ENDOCRINOL, V54, pR131, DOI 10.1530/JME-14-0315
- Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160
- Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459
- Carrion AM, 1999, NATURE, V398, P80
- Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473
- de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361
- Grandone A, 2017, HORM RES PAEDIAT, V88, P194, DOI 10.1159/000477441
- Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199
- Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783
- Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0
- Leclerc GM, 2007, MOL CELL ENDOCRINOL, V267, P70, DOI 10.1016/j.mce.2006.12.040
- Leclerc GM, 2002, GEN COMP ENDOCR, V129, P45, DOI 10.1016/S0016-6480(02)00509-9
- Macedo DB, 2014, J CLIN ENDOCR METAB, V99, pE1097, DOI 10.1210/jc.2013-3126
- Macedo DB, 2014, NEUROENDOCRINOLOGY, V100, P1, DOI 10.1159/000366282
- MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E
- Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218
- NEELY EK, 1995, J PEDIATR-US, V127, P40, DOI 10.1016/S0022-3476(95)70254-7
- NEWBURGER PE, 1994, J CLIN INVEST, V94, P1205, DOI 10.1172/JCI117437
- Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2
- Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493
- Simon D, 2016, EUR J ENDOCRINOL, V174, P1, DOI 10.1530/EJE-15-0488
- SPEK CA, 1995, J BIOL CHEM, V270, P24216, DOI 10.1074/jbc.270.41.24216
- Ortiz-Cabrera NV, 2017, HORM RES PAEDIAT, V87, P88, DOI 10.1159/000453262